Capital International Sarl’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$93.3M	Buy	208,882 +15,444	+8%	+$7.2M	1.53%	14
2025 Q4	$87.7M	Sell	193,438 -32,296	-14%	-$13.9M	1.41%	15
2025 Q3	$88.4M	Buy	225,734 +2,345	+1%	+$980K	1.53%	15
2025 Q2	$99.5M	Buy	223,389 +37,218	+20%	+$17.2M	1.91%	9
2025 Q1	$90.3M	Buy	186,171 +17,579	+10%	+$8.19M	2.04%	9
2024 Q4	$67.9M	Buy	168,592 +25,544	+18%	+$11.8M	1.57%	12
2024 Q3	$66.5M	Buy	143,048 +18,968	+15%	+$9.11M	1.71%	9
2024 Q2	$58.2M	Buy	124,080 +7,602	+7%	+$3.3M	1.78%	10
2024 Q1	$48.7M	Buy	116,478 +22,891	+24%	+$9.68M	1.61%	9
2023 Q4	$38.1M	Buy	93,587 +14,113	+18%	+$5.21M	1.43%	10
2023 Q3	$27.6M	Buy	79,474 +5,799	+8%	+$2.03M	1.26%	17
2023 Q2	$25.9M	Buy	73,675 +15,253	+26%	+$5.14M	1.16%	16
2023 Q1	$18.4M	Buy	58,422 +7,652	+15%	+$2.3M	0.93%	28
2022 Q4	$14.7M	Buy	50,770 +3,057	+6%	+$932K	1.03%	22
2022 Q3	$13.8M	Buy	47,713 +4,461	+10%	+$1.28M	1.12%	16
2022 Q2	$12.2M	Buy	43,252 +1,225	+3%	+$328K	0.98%	17
2022 Q1	$11M	Sell	42,027 -4,528	-10%	-$1.07M	0.54%	53
2021 Q4	$10.2M	Buy	46,555 +33,939	+269%	+$6.6M	0.49%	60
2021 Q3	$2.29M	Sell	12,616 -2,214	-15%	-$432K	0.2%	123
2021 Q2	$2.99M	Buy	14,830 +341	+2%	+$71.3K	0.26%	106
2021 Q1	$3.11M	Buy	14,489 +374	+3%	+$82.1K	0.3%	93
2020 Q4	$3.34M	Buy	14,115 +393	+3%	+$90.2K	0.35%	87
2020 Q3	$3.73M	Buy	13,722 +536	+4%	+$148K	0.46%	70
2020 Q2	$3.83M	Buy	13,186 +2,424	+23%	+$657K	0.51%	59
2020 Q1	$2.56M	Buy	10,762 +3,188	+42%	+$731K	0.47%	64
2019 Q4	$1.66M	Buy	+7,574	New	+$1.53M	0.26%	104